our preliminary results of benzylation chemistry, we were aware that catalysts derived from nickel were able to furnish the benzylated products, albeit in very low yield. Considering the success of nickel in catalyzing reactions of diverse nucleophiles with unactivated alkyl halides, we turned our attention to nickel catalysis. After extensive investigation of different ligands and conditions, we found the optimum ligand to be bathocuproine. The use of ethereal solvents was important, since the insolubility of the nitronate anion in these solvents precludes the competing O-alkylation reaction. Finally, suitable conditions were developed for a nickel(II) source and external reductant to make the reaction more user-friendly, considering the instability of Ni(0) sources such as Ni(cod) 2 ."
With the optimized conditions in hand, the group then set out to examine the substrate scope and functional group tolerance of the reaction. "Gratifyingly, primary, secondary, and tertiary alkyl iodides were all reactive and gave the complex C-alkylated nitroalkane products in moderate to good yields," said Professor Watson. "We particularly focused on examining relevant and important bioactive functional groups and heterocycles, and in most cases, they did not interfere with the reaction. A variety of functionalized nitroalkanes were also tested and they worked well too. Significantly, an anti-viral drug, adapromine, could be synthesized in two steps with good yields using this method." "While we believe that this newly reported method makes a major advance in nitroalkane alkylation, there is still
